PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES OF ASSOCIATES OF COPPER NANOPARTICLES
- Авторы: Borodulin V.B.1, Matasov A.D.2,3, Goroshinskaya I.A.4, Okunev I.S.2, Petrov S.N.5, Drozdova N.F.5, Kachesova P.S.4, Losev O.E.1, Bobyleva E.V.1, Zlatnik E.Y.4, Chebotareva E.G.1, Lazarenko Y.S.1, Bobylev A.V.1, Borodulina E.V.1
-
Учреждения:
- Saratov State Medical University, Russian Ministry of Health
- Konstantinov St. Petersburg Institute of Nuclear Physics
- Ioffe Institute
- Rostov Research Institute of Oncology, Russian Ministry of Health
- Prometey
- Выпуск: Том 14, № 1-2 (2019)
- Страницы: 74-81
- Раздел: Nanobiomedicine and Nanopharmaceuticals
- URL: https://journals.rcsi.science/2635-1676/article/view/220724
- DOI: https://doi.org/10.1134/S1995078019010038
- ID: 220724
Цитировать
Аннотация
Abstract—The physicochemical parameters of associates of unstabilized copper nanoparticles (NPs) obtained by the plasma-chemical method were studied. Optical methods were used to determine the size of NP associates, including atomic force microscopy, spectrophotometry, and fluorometry. The sizes of copper NPs varied from 30 to 75 nm, and the sizes of NP associates, from 481.1 to 1037 nm. The phase composition of copper NPs was analyzed by X-ray diffractometry using a Rigaku Ultima IV multifunctional X-ray diffractometer. An oxide film without an admixture of organic molecules was found on the surface of NP associates. The effect of copper NPs on an A549 cell culture was studied. A change was observed in the biochemical parameters of blood serum of outbred mice under the influence of copper NPs. The antitumor effect of copper NPs was revealed, and its intensity was compared to different methods of administering NP to animals with fibrosarcoma (S-45) and Pliss lymphosarcoma.
Об авторах
V. Borodulin
Saratov State Medical University, Russian Ministry of Health
Автор, ответственный за переписку.
Email: borodulinvb@mail.ru
Россия, Saratov
A. Matasov
Konstantinov St. Petersburg Institute of Nuclear Physics; Ioffe Institute
Email: borodulinvb@mail.ru
Россия, St. Petersburg; St. Petersburg
I. Goroshinskaya
Rostov Research Institute of Oncology, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Rostov-on-Don
I. Okunev
Konstantinov St. Petersburg Institute of Nuclear Physics
Email: borodulinvb@mail.ru
Россия, St. Petersburg
S. Petrov
Prometey
Email: borodulinvb@mail.ru
Россия, St. Petersburg
N. Drozdova
Prometey
Email: borodulinvb@mail.ru
Россия, St. Petersburg
P. Kachesova
Rostov Research Institute of Oncology, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Rostov-on-Don
O. Losev
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Saratov
E. Bobyleva
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Saratov
E. Zlatnik
Rostov Research Institute of Oncology, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Rostov-on-Don
E. Chebotareva
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Saratov
Ya. Lazarenko
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Saratov
A. Bobylev
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Saratov
E. Borodulina
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
Россия, Saratov
Дополнительные файлы
